Consideraciones clínicas y desenlaces quirúrgicos del cáncer asociado a implante mamario: Una enfermedad emergente de interés: Clinical considerations and surgical outcomes of breast implant-associated cancer: An emerging disease of interest

Abel Enrique Manjarres Guevara; Miguel Andres Montalvo Clavijo; Fares Juan José Martinez Sierra; Diego Armando Franco Arias; Nathalia Maria Esmeral Zuluaga; Astrid Juliana Velandia Suárez; Yarath Zeneth Rodríguez Cabarca; Michael Gregorio Ortega Sierra

doi:10.25176/RFMH.v23i2.5652

Authors

Abel Enrique Manjarres Guevara Departamento de Medicina, Universidad del Norte, Barranquilla, Colombia.
Miguel Andres Montalvo Clavijo Universidad de Ciencias Médicas de la Habana, La Habana, Cuba.
Fares Juan José Martinez Sierra Departamento de Medicina, Universidad del Norte, Barranquilla, Colombia. https://orcid.org/0000-0001-9035-9559
Diego Armando Franco Arias Clínica Interquirofanos, Medellín, Colombia. https://orcid.org/0000-0001-8287-7241
Nathalia Maria Esmeral Zuluaga Departamento de Medicina, Universidad Icesi, Cali, Colombia.
Astrid Juliana Velandia Suárez Departamento de Medicina, Universidad de la Sabana, Chía, Colombia.
Yarath Zeneth Rodríguez Cabarca Departamento de Medicina, Corporación Universitaria Rafael Núñez, Cartagena, Colombia. https://orcid.org/0000-0002-2400-4511
Michael Gregorio Ortega Sierra Universidad Centroccidental Lisandro Alvarado - Hospital Central Antonio María Pineda, Barquisimeto, Venezuela.

DOI:

https://doi.org/10.25176/RFMH.v23i2.5652

Keywords:

Breast neoplasms, male breast neoplasms, anaplastic large-cell lymphoma, health care outcome assessment, treatment outcome

Abstract

Breast cancer continues to be one of the main priorities in global health and public health, and remains the most frequent and deadly malignant neoplasm in women worldwide. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare type of non-Hodgkin's lymphoma, whose pathogenesis and pathophysiology are not well known, but which is seen with increasing frequency due to the increase in cosmetic procedures. To date, there are limitations in terms of knowledge about the clinical behavior of the disease, which can manifest itself in many forms, with a variable evolution time and uncertain surgical outcomes in the medium- and long-term. Based on the above, the aim of this review is to summarize evidence on the clinical considerations and surgical outcomes of breast implant-associated cancer to facilitate the identification and management of this condition. A bibliographic search was performed in the search engines and databases PubMed, ScienceDirect, Embase, EBSCO and MEDLINE. Within the clinical and surgical considerations, the type of implant used (textured), the time of the implant history, the severity of the manifestations, and the staging, must be taken into account in order to determine the opportunity for surgical intervention and neoadjuvant therapy, and to try to guarantee survival and avoid recurrence. Patients who undergo complete capsulectomy with radiotherapy have better outcomes.

Downloads

Download data is not yet available.

References

Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022; 66:15-23. doi: 10.1016/j.breast.2022.08.010

World Health Organization. Breast cancer. (Consultado en febrero 17 de 2023). Disponible en: https://www.who.int/news-room/fact-sheets/detail/breast-cancer

Li N, Deng Y, Zhou L, Tian T, Yang S, Wu Y, et al. Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017. J Hematol Oncol. 2019; 12(1):140. doi: 10.1186/s13045-019-0828-0

Pedersen RN, Esen BÖ, Mellemkjær L, Christiansen P, Ejlertsen B, Lash TL, et al. The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis. J Natl Cancer Inst. 2022; 114(3):391-399. doi: 10.1093/jnci/djab202

Abubakar M, Sung H, Bcr D, Guida J, Tang TS, Pfeiffer RM, et al. Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population. Breast Cancer Res. 2018; 20(1):114. doi: 10.1186/s13058-018-1033-8

Kricheldorff J, Fallenberg EM, Solbach C, Gerber-Schäfer C, Rancsó C, Fritschen UV. Breast Implant-Associated Lymphoma. Dtsch Arztebl Int. 2018; 115(38):628-635. doi: 10.3238/arztebl.2018.0628

Marra A, Viale G, Pileri SA, Pravettoni G, Viale G, De Lorenzi F, et al. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review. Cancer Treat Rev. 2020; 84:101963. doi: 10.1016/j.ctrv.2020.101963

Leberfinger AN, Behar BJ, Williams NC, Rakszawski KL, Potochny JD, Mackay DR, et al. Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Systematic Review. JAMA Surg. 2017; 152(12):1161-1168. doi: 10.1001/jamasurg.2017.4026

Locke MB, Lofts J. Variable presentation of anaplastic large-cell lymphoma in patients with breast implants. ANZ J Surg. 2017; 87(10):789-794. doi: 10.1111/ans.13074

Fitzal F, Turner SD, Kenner L. Is breast implant-associated anaplastic large cell lymphoma a hazard of breast implant surgery? Open Biol. 2019; 9(4):190006. doi: 10.1098/rsob.190006

Sharma K, Gilmour A, Jones G, O'Donoghue JM, Clemens MW. A Systematic Review of Outcomes Following Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). JPRAS Open. 2022; 34:178-188. doi: 10.1016/j.jpra.2022.08.008

Jaffe ES, Ashar BS, Clemens MW, Feldman AL, Gaulard P, Miranda RN, et al. Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma. J Clin Oncol. 2020; 38(10):1102-1111. doi: 10.1200/JCO.19.02778

US Food and Drug Administration. Medical Device Reports of Breast Implant-Associated Anaplastic Large Cell Lymphoma [Internet]. [Consultado 21 Feb 2023]. Disponible en: https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm481899.htm

McCarthy CM, Loyo-Berríos N, Qureshi AA, Mullen E, Gordillo G, Pusic AL, et al. Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): Initial Report of Findings, 2012-2018. Plast Reconstr Surg. 2019; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):65S-73S. doi: 10.1097/PRS.0000000000005571

George EV, Pharm J, Houston C, Al-Quran S, Brian G, Dong H, et al. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis. Int J Clin Exp Pathol. 2013; 6(8):1631-42. Disponible en: https://pubmed.ncbi.nlm.nih.gov/23923082/

Jones JL, Hanby AM, Wells C, Calaminici M, Johnson L, Turton P, et al. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management. Histopathology. 2019; 75(6):787-796. doi: 10.1111/his.13932

Bewtra C, Gharde P. Current Understanding of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Cureus. 2022; 14(10):e30516. doi: 10.7759/cureus.30516

Oishi N, Miranda RN, Feldman AL. Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Aesthet Surg J. 2019; 39(Suppl_1):S14-S20. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30715169/

Kadin ME, Deva A, Xu H, Morgan J, Khare P, MacLeod RA, et al. Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2016; 36(7):773-81. doi: 10.1093/asj/sjw023

Brinton LA. The relationship of silicone breast implants and cancer at other sites. Plast Reconstr Surg. 2007; 120(7 Suppl 1):94S-102S. doi: 10.1097/01.prs.0000286573.72187.6e

Wang Y, Zhang Q, Tan Y, Lv W, Zhao C, Xiong M, et al. Current Progress in Breast Implant-Associated Anaplastic Large Cell Lymphoma. Front Oncol. 2022; 11:785887. doi: 10.3389/fonc.2021.785887

Orciani M, Sorgentoni G, Torresetti M, Di Primio R, Di Benedetto G. MSCs and inflammation: new insights into the potential association between ALCL and breast implants. Breast Cancer Res Treat. 2016; 156(1):65-72. doi: 10.1007/s10549-016-3745-8

Ionescu P, Vibert F, Amé S, Mathelin C. New Data on the Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Eur J Breast Health. 2021; 17(4):302-307. doi: 10.4274/ejbh.galenos.2021.2021-5-6

Tevis SE, Hunt KK, Miranda RN, Lange C, Pinnix CC, Iyer S, et al. Breast Implant-associated Anaplastic Large Cell Lymphoma: A Prospective Series of 52 Patients. Ann Surg. 2022; 275(1):e245-e249. doi: 10.1097/SLA.0000000000004035

Cordeiro PG, Ghione P, Ni A, Hu Q, Ganesan N, Galasso N, et al. Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants. J Plast Reconstr Aesthet Surg. 2020; 73(5):841-846. doi: 10.1016/j.bjps.2019.11.064

Patzelt M, Zarubova L, Klener P, Barta J, Benkova K, Brandejsova A, et al. Anaplastic Large-Cell Lymphoma Associated with Breast Implants: A Case Report of a Transgender Female. Aesthetic Plast Surg. 2018; 42(2):451-455. doi: 10.1007/s00266-017-1012-y

Nelson JA, Dabic S, Mehrara BJ, Cordeiro PG, Disa JJ, Pusic AL, et al. Breast Implant-associated Anaplastic Large Cell Lymphoma Incidence: Determining an Accurate Risk. Ann Surg. 2020; 272(3):403-409. doi: 10.1097/SLA.0000000000004179

Villarroya-Marquina I, Moshrefi S, Sheckter C, Lee GK. European Attitudes and Outcomes Regarding Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Multinational Survey. Aesthetic Plast Surg. 2020; 44(5):1387-1395. doi: 10.1007/s00266-020-01736-9

Xia Z, Han B, Wang L, Ning G, Guo Z, Zhang J, et al. Breast implant-associated squamous cell carcinoma in a male patient: A case report and review of the medical literature. Front Surg. 2023; 9:983611. doi: 10.3389/fsurg.2022.983611

Lynch EB, DeCoster RC, Vyas KS, Rinker BD, Yang M, Vasconez HC, et al. Current risk of breast implant-associated anaplastic large cell lymphoma: a systematic review of epidemiological studies. Ann Breast Surg. 2021; 5:30. doi: 10.21037/abs-20-96

Cunha A, Horta R, Barreiro D. Epidemiological Profile in Portugal of Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Cross-Sectional Study. Acta Med Port. 2021; 34(9):572-579. doi: 10.20344/amp.14055

Collett DJ, Rakhorst H, Lennox P, Magnusson M, Cooter R, Deva AK. Current Risk Estimate of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants. Plast Reconstr Surg. 2019; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):30S-40S. doi: 10.1097/PRS.0000000000005567

Nelson JA, McCarthy C, Dabic S, Polanco T, Chilov M, Mehrara BJ, et al. BIA-ALCL and Textured Breast Implants: A Systematic Review of Evidence Supporting Surgical Risk Management Strategies. Plast Reconstr Surg. 2021; 147(5S):7S-13S. doi: 10.1097/PRS.0000000000008040

Lillemoe HA, Miranda RN, Nastoupil LJ, Clemens MW, Hunt KK. Clinical Manifestations and Surgical Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Beyond the NCCN Guidelines. Ann Surg Oncol. 2022; 29(9):5722-5729. doi: 10.1245/s10434-022-11838-0

Lamaris GA, Butler CE, Deva AK, Miranda RN, Hunt KK, Connell T, et al. Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma. Plast Reconstr Surg. 2019; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):51S-58S. doi: 10.1097/PRS.0000000000005569

Nestler JA, Kim JK, Goodreau AM, Mountziaris PM, McGuire KP. Invasive stage III breast implant-associated anaplastic large cell lymphoma successfully treated with incomplete resection. BMJ Case Rep. 2022; 15(4):e246664. doi: 10.1136/bcr-2021-246664

Collins MS, Miranda RN, Medeiros LJ, Silva de Meneses MP, Iyer SP, Butler CE, et al. Characteristics and Treatment of Advanced Breast Implant-Associated Anaplastic Large Cell Lymphoma. Plast Reconstr Surg. 2019; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):41S-50S. doi: 10.1097/PRS.0000000000005568

Di Napoli A, Firmani G, Sorotos M, Lopez G, Noccioli N, De Sanctis V, et al. Successful Treatment of a Patient With Breast Implant-Associated Anaplastic Large Cell Lymphoma With Local Residual Disease: A Case Report. Ann Plast Surg. 2022; 88(2):152-156. doi: 10.1097/SAP.0000000000003033

Foroushani FT, Dzobo K, Khumalo NP, Mora VZ, de Mezerville R, Bayat A. Advances in surface modifications of the silicone breast implant and impact on its biocompatibility and biointegration. Biomater Res. 2022; 26(1):80. doi: 10.1186/s40824-022-00314-1

Mempin M, Hu H, Chowdhury D, Deva A, Vickery K. The A, B and C's of Silicone Breast Implants: Anaplastic Large Cell Lymphoma, Biofilm and Capsular Contracture. Materials (Basel). 2018; 11(12):2393. doi: 10.3390/ma11122393

Reyes A, Torregrosa L, Lozada-Martinez ID, Cabrera-Vargas LF, Nunez-Ordonez N, Martínez Ibata TF. Breast cancer mortality research in Latin America: A gap needed to be filled. Am J Surg. 2023; S0002-9610(23)00009-0. doi: 10.1016/j.amjsurg.2023.01.010

Reyes-Monasterio A, Lozada-Martinez ID, Cabrera-Vargas LF, Narvaez-Rojas AR. Breast cancer care in Latin America: The ghost burden of a pandemic outbreak. Int J Surg. 2022; 104:106784. doi: 10.1016/j.ijsu.2022.106784

Lozada-Martinez ID, Suarez-Causado A, Solana-Tinoco JB. Ethnicity, genetic variants, risk factors and cholelithiasis: The need for eco-epidemiological studies and genomic analysis in Latin American surgery. Int J Surg. 2022; 99:106589. doi: 10.1016/j.ijsu.2022.106589